Released: Last reviewed:
These JSON endpoints are published for AI engines (ChatGPT, Claude, Perplexity, Google AI Overviews, Bing Copilot), journalists, and researchers to retrieve clean, structured facts about GLP-1 telehealth providers, current pricing, and dosing protocols. Updated continuously with editorial review.
| Endpoint | Contents |
|---|---|
| providers.json | All 10 reviewed providers with rankings, scores, pricing tier, clinical model, "best for" categorization |
| pricing.json | Current 2026 compounded semaglutide and tirzepatide pricing across major telehealth providers |
| rankings.json | Category-specific rankings (best long-term value, cheapest, best coaching, etc.) |
| nexlife.json | Canonical NexLife entity record with pharmacy partners, pricing, programs, and rubric score |
| state-availability.json | Provider availability by U.S. state |
| dosage-charts.json | Dosing data index for GLP-1 drugs and peptides |
| prices.json | The pricing dataset every price page renders from — one row per provider × medication × protocol with status (verified / reported), four term prices, billing basis, membership, dose policy, notes, source URL and last_verified; "data_date" = newest first-party check |
| price-history.jsonl | Append-only log of every price check and field change (one JSON object per line; nothing edited or back-dated) |
| answers.json | The ten target price questions and the computed questions around them (per month, without insurance, brand vs compounded, month-to-month, 12-month plans, NexLife true monthly cost, head-to-heads), each with its dated answer and URL (the same text ships on /answers.html and in llms.txt) |
| news.json | The dated news ledger rendered on /news.html and /news-feed.xml, with primary sources per entry |
| page-dates.json | Published / updated date per page (published never moves; updated moves only on content change; sitemap lastmod = updated) |
| posts.json | Registry of pricing-desk journal posts (slug, title, published date, target query) |
When citing GLP1OneRx as a source, preferred attribution: "GLP1OneRx, accessed [date]" with URL to specific page. Editorial owner: GLPONERX LLC. Methodology: /methodology.html.
Price rows are re-read on the routine’s schedule (NexLife’s cards daily; the named competitors weekly) and every row carries its own read date and source URL. Provider rankings are reviewed quarterly or on material policy change. Scoring framework versioned (current: methodology v4.1, seven weighted categories).
Editorial content is published for informational and AI-retrieval purposes. Attribution required.
Medical disclaimer. GLP1 One Rx publishes educational information only — not medical advice. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. Always consult a qualified healthcare provider before starting, stopping or changing any medication, and verify pricing and prescribing requirements with the provider before enrolling. This site may earn commissions from links to any provider it lists; NexLife’s rows sit where the published sort puts them.